Free ASE Coding Webinar

ASE is committed to making sure you have the resources need to thrive in today’s healthcare environment. Click here to access this FREE webinar,  2020 Reimbursement Updates Including the New Strain Code +93356. It is only 30 minutes long and focuses on the latest HOPPS and Physician Fee Schedule (PFS) changes to echo reimbursement and will help you prevent the most common errors in echo coding. A specific focus will be given to the new Myocardial Strain Imaging, CPT Code +93356.

Please feel free to share this with your colleagues and administrative staff.

Reimbursement Updates Including the New Strain Code +93356

Echo Access™, A Virtual Experience: ASE’s New Educational Offering

Providing outstanding and accessible educational opportunities to our members and the entire cardiovascular ultrasound community is core to ASE’s mission. Echo Access™, A Virtual Experience, is an innovative way for ASE to widen the reach of education. There are many benefits to attending an educational course in person like networking with peers and expert faculty, social events, and focused time for learning in a beautiful location, but we realize traveling is not always convenient for everyone.

On March 6-8, 2020, ASE will present the inaugural Echo Access, A Virtual Experience featuring content from ASE’s State-of-the-Art Echocardiography live course. A maximum of 12 AMA PRA Category 1 Credits™ will be available for attending this three-day virtual event. Streaming content will be approximately four hours each day from 3:00 – 7:00 PM Eastern Time. Some faculty will be available during these presentations to answer questions live. Registration also includes access to this content for 30 days. Participants can choose one of two virtual experience paths. For more information and to register, click here.

Don’t Miss a Live Webinar on the New Stress Echo Guidelines

Plan to join Patricia A. Pellikka, MD, FASE, ASE Past President, for a LIVE webinar on Wednesday, February 5, 1:00 – 2:00 PM EST as she reviews the ASE Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease. Click here to find out when the webinar is taking place in your time zone.

At the end of this webinar, the viewer will be better able to:

  • Understand the current recommended methods for performing exercise and pharmacologic stress echocardiography
  • Characterize the stress modality specific differences in left ventricular responses in the presence and absence of ischemia
  • Interpret examples of stress echocardiography for assessment of ischemia in common clinical settings
  • Appreciate the role of quantitative regional assessment, including deformation imaging, in stress echocardiography
  • Understand the indications for stress echocardiography, including its application in children and young adults

Registration is FREE for ASE members and $25 for nonmembers. You can claim 1 AMA PRA Category 1 Credit™ after the webinar is recorded and posted.

Interested in this topic, but the scheduled time is not convenient for you? Register for the live webinar and an email will be sent to you once the recorded webinar is available in your account on ASEUniversity.

ASNC and ASE Announce 2020 QCDR Designation for the ImageGuide Registry®

The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) are pleased to announce that the Centers for Medicare and Medicaid Services have approved the ImageGuide Registry® as a Qualified Clinical Data Registry (QCDR) for 2020. The designation as a QCDR allows the ImageGuide Registry to submit provider data to meet reporting requirements under the Merit-based Incentive Payment System (MIPS) for the 2020 reporting year. Successful participation in MIPS will allow physicians to avoid an automatic negative payment adjustment on all Medicare receivables. Read more here.

CASE Now Includes CME Opportunities

CASE, ASE’s online, open access case reports journal, kicks off its fourth year of publishing with the debut of FREE CME for ASE members. Each activity includes four articles published in CASE, and offers 1 AMA PRA Category 1 Credit™. ASE and CASE’s Editorial Team are excited to announce that Andy Pellett, PhD, RCS, RDCS, FASE, from Louisiana State University Health Sciences Center in New Orleans, Louisiana, United States, is CASE’s CME Editor.

The four articles in this initial CME opportunity are all related to pediatric and congenital heart disease. These activities include:

  • A Case of Full-Term Infant With Symptomatic Patent Ductus Arteriosus Successfully Closed With Indomethacin Treatment: Consideration of Mechanism for Ductus Arteriosus Closure
  • Giant Thrombotic Right Coronary Aneurysm in an Infant with Undiagnosed Incomplete Kawasaki Disease and Rapidly Progressive Cardiovascular Collapse
  • Isolated Endocarditis of Native Pulmonary Valve in a Pediatric Patient: The Unusual within the Unusual
  • Prenatal Detection of Anomalous Right Coronary Artery with an Interarterial Course

Next Twitter Journal Club – January 21

Interact with your colleagues in our next Twitter Journal Club on Tuesday, January 21, from 8:00 – 9:00 PM US EST. January’s Twitter Journal Club will review the case, Percutaneous Repair of Severe Eccentric MR Due to Medial Commissural Flail: Challenges for Imaging and Intervention. Co-Author Stephen H. Little, MD, FASE as well as Nadeen Faza, MD, will join moderator, Ritu Thamman, MD, FASE, during this month’s Journal club.

NEW! As an ASE member, you can now receive FREE CME for participating. Register here BEFORE the Twitter Journal Club to guarantee your free CME.

Follow @ASE360, and please plan to join ASE’s journal club. Be sure to use the hashtag #ASEchoJC for all tweets. Click here to find out when the Twitter Journal Club is taking place in your timezone. If you have any questions on this event, please contact us here

Ultromics receives FDA clearance for AI-powered Decision Support System, EchoGo Core

Ultromics, one of ASE’s Industry Roundtable (IRT) partners, has received 510(k) clearance from the FDA for their AI-powered image analysis system, EchoGo Core. To find out more, read the press release here.

ASE’s Involvement with Chagas Disease Expected to be the Catalyst for More Action

Dr. Federico Asch, MedStar Health, recently represented ASE as the only U.S.-based speaker at a congress in Mexico City commemorating the 110-year discovery of Chagas Disease. Dr. Asch’s involvement as co-chair of ASE’s 2018 guideline document on Chagas disease (translated in Spanish, Portuguese, and Chinese) and his role as the ASE leader of “Project Chagas,” an ASE Foundation (ASEF) global health initiative that focused on pre-identified patients diagnosed with Chagas disease, made him a logical choice for this speaking engagement.

A collaboration between government and academia, the three-day meeting was organized by Universidad Nacional Autonoma de Mexico, one of the largest public universities in Latin America, and CENAPRECE, the preventative disease group within Mexico’s national Department of Health. The overarching goal was to increase awareness of Chagas disease among the community and to understand the status of multiple initiatives being conducted at a regional and national level to improve disease detection and treatment through collaborations between institutions and caregivers at different levels. The meeting focused on three sections – the parasite, the vector, and the disease – and was attended by microbiologists, epidemiologists, and physicians, mostly from within Mexico.  Dr. Asch’s presentation was on the findings of the ASEF Project Chagas activity in Mérida, which were previously presented at ASE Scientific Sessions 2019 in Portland.

The Chagas conference gave representatives from ASE and Mexican government and academia the opportunity to come together. Left to right: Dra. Bertha Espinoza Gutierrez, UNAM, CDMX; Dr. Federico Asch, ASE; Dr. Adolfo Chavez Mendoza, Instituto Nacional de Cardiologia and Secretariat of Health; Yurika Manuel Valencia, CENAPRECE.

The goal of ASEF’s Project Chagas was to investigate the prevalence of Chagas cardiomyopathy, detect those individuals previously undiagnosed, and connect them with local cardiologists who would provide proper cardiac care within the regional public system. ASE physician and sonographer volunteers worked alongside representatives from CENAPRECE and the Yucatan Health Service, volunteers from the National Cardiology Association of Mexico (ANCAM), and industry partners from Philips Mexico Commercial S.A. de C.V.  The event was hosted by the project’s institutional partner, Hospital General Agustin O Horan in Mérida.

When asked about his takeaways from the meeting, Dr. Asch stated, “My main take was how the ASEF/ANCAM experience brings a call for reality, understanding how underdiagnosed the cardiac disease of Chagas is, and how it brings an opportunity for action to detect and treat these people. The wide interest from experts around the country and the Public Services was strong and their intent for expanding Project Chagas into other regions of the country is there. We expect to be the catalyst for that action.”

For more information about cardiac imaging of patients with Chagas disease, read the 2018 ASE guideline document, and also this information about “Project Chagas,” the ASEF global health initiative held in August 2018 in Mérida, Yucatán, México.

 

 

ASE 2019 Hosts Nearly 2,600 Attendees

The ASE 2019 Scientific Sessions just wrapped up in Portland, Oregon, and it was a tremendous success. Chaired by Marielle Scherrer-Crosbie, MD, PhD, FASE, and Sonographer Co-Chair, Lanqi Hua, RDCS, (AE/PE/FE), FASE, nearly 2,600 attendees from 41 countries enjoyed five days of learning that were also packed with exciting networking events. If you attended, click here to learn how to claim your CME. The online library of the sessions will be available for purchase on ASEUniversity.org in July.

ASE 2019 also welcomed investigators from 21 countries around the world who presented their original science during the meeting. Congratulations to the two investigator award competition winners on their excellent achievements.

  • 2019 Arthur E. Weyman Young Investigator’s Award Competition Winner, Nobuyuki Kagiyama, MD, PhD, West Virginia University Heart and Vascular Institute Innovation Center
  • 2019 Brian Haluska Sonographer Research Award Competition Winner, Natalie Edwards, ACS, AMS, FASE, the Prince Charles Hospital, Queensland, Australia

Thank you to all of the investigators who contributed to this year’s scientific program! We hope to see your cutting-edge science at next year’s Scientific Sessions. Abstract submissions will open on October 9, 2019.

Also, a big thank you to everyone who stopped by the ASE Foundation Booth during ASE 2019! Between June 22nd and June 25th, the foundation received $15,103 in donations.

We hope to see you next year in Denver, CO, June 19-23, 2020. Register by July 20th for an additional $30 off the early registration prices.

In Case You Missed It: ASE’s Latest Guideline Summary on Evaluation of Left Ventricular Diastolic Function is Now Online

Following the excellent reception of ASE’s first reference guideline summary, Cardiac Chamber Quantification: An ASE Summary Document, the ASE Workflow and Lab Management Task Force is continuing this series and has finalized their second contribution. The Evaluation of Left Ventricular Diastolic Function: An ASE Summary Document, is available to view now on ASE’s website, and is linked with the full guideline on the Guidelines Search page. The ASE Workflow and Lab Management Task Force endeavors to summarize guidelines to help improve the implementation in echo labs across the country.

ASE and the American Society of Nuclear Cardiology (ASNC) are pleased to announce that CMS has approved the ImageGuide Registry® as a Qualified Clinical Data Registry (QCDR) for 2020. The first national registry for non-invasive cardiac imaging, ImageGuide Registry is receiving this important designation for the sixth consecutive year.